Stem Cells and Cardiovascular Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 8180
Special Issue Editor
Special Issue Information
Dear Colleagues,
Stem cell-based therapies have emerged as the very promising treatment modality in cardiovascular diseases. Despite advances in stem cell research, the efficacy of stem cell therapy for ischemic heart disease is paradoxical, as no statistically significant improvements in infarct size, cardiac function, or cardiovascular remodeling were observed in most clinical studies. The disappointing results from previous clinical trials could be caused by inappropriate delivery route, timing, cell distribution post administration, or the mechanism of action, etc.
To better understand stem cell-based therapies in cardiovascular diseases, we invite both original articles and reviews that cover (but are not limited to) the following topics:
- Stem cell-derived extracellular vesicles/exosomes in cardiovascular repair;
- Epigenetic modification of stem cells in cardiovascular regeneration;
- Microenvironment in stem cell therapeutic efficacy;
- Single-cell RNA sequencing in stem cell research;
- Disease models using human iPSC-derived cardiomyocytes;
- Biomaterials-based delivery of stem cells in myocardial infarction;
- Biological activities of endogenous cardiac progenitor cells after myocardial ischemia.
Dr. Meijing Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cells
- cardiac regeneration
- paracrine action
- epigenetic regulation
- myocardial ischemia
- extracellular vesicles/exosomes
- iPSC
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.